| Quarter | Score |
|---|---|
| 2022-Q1 | 51.0 |
| 2022-Q3 | 65.9 |
| 2022-Q4 | 49.6 |
| 2023-Q1 | 50.8 |
| 2023-Q2 | 63.9 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 66.2 |
| 2024-Q1 | 73.1 |
| 2024-Q2 | 73.3 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.6 |
| 2025-Q2 | 61.7 |
| 2025-Q3 | 61.5 |
| 2025-Q4 | 86.7 |
| 2026-Q1 | 81.3 |
| 2026-Q2 | 83.0 |
Solid consensus with smart money net adding at reasonable prices
Trading +18.0% above funds' estimated purchase price
4 of 18 tracked funds hold CROX. Avg conviction: 1.4%. Net holding. First tracked at $99.09 (current +18.0% vs tracked).
Himalaya Capital Management has 2.9% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Himalaya Capital Management | 2.9% | Hold |
| Greenlight Capital | 2.1% | Hold |
| Miller Value Partners | 0.8% | Reduce |
| Citadel Advisors |
| 0.0% |
| Add |